In this study, ex vivo generated CD3+TCRαβ+NK1.1-CD4-CD8- DNT cells were adoptively transferred to ischemic stroke mice to identify their therapeutic effects and immunological mechanisms. The gene discussed is CD8A; the disease is ischemic stroke.